Defective acid sphingomyelinase pathway with Pseudomonas aeruginosa infection in cystic fibrosis

Hong Yu, Youssef Zeidan, Bill X. Wu, Russell W. Jenkins, Terence R. Flotte, Yusuf A. Hannun, Isabel Virella-Lowell

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

Acid sphingomyelinase (ASMase) is a key enzyme in sphingolipid metabolism, which can be activated by various cellular stress mechanisms including bacterial pathogens. Activation of ASMase generates ceramide, which is important for innateimmuneresponse to eliminate infected pathogens. The current study reveals a defective ASMase pathway after Pseudomonas aeruginosa infection in both a cystic fibrosis (CF) bronchial epithelial cell line (IB3-1 cell) and in the lungs of CF transmembrane conductance regulator (CFTR) knockout (KO) mice as compared with S9 cells and wild-type C57BL/6 mice. ASMase activity and total ceramide levels significantly increased in S9 cells and C57BL/6 mice with P. aeruginosa infection, but not in IB3-1 cells and CFTR KO mice. The silencing of CFTR by CFTR RNAi in S9 cells significantly decreased ASMase activity after bacterial infection as compared with controls. This study also demonstrates that induction of ASMase is responsible for modulating the immune response to bacterial infection. Blocking ASMase activity with specific ASMase RNAi, an ASMase inhibitor, or an ASMase antibody in S9 cells significantly increased IL-8 levels with P. aeruginosa infection compared with controls. Reciprocally, adding exogenous bacterial sphingomyelinase to IB3-1 cells significantly decreased IL-8 levels compared with untreated cells. In addition, silencing of ASMase in S9 cells also significantly decreased bacterial internalization. Adding exogenous bacterial sphingomyelinase to IB3-1 cells reconstituted the cell death response to P. aeruginosa infection. This study demonstrates that the defective ASMase pathway in CF is a key contributor to the unabated IL-8 response with P. aeruginosa infection and to the compromised host response failing to eradicate bacteria.

Original languageEnglish (US)
Pages (from-to)367-375
Number of pages9
JournalAmerican Journal of Respiratory Cell and Molecular Biology
Volume41
Issue number3
DOIs
StatePublished - Sep 1 2009
Externally publishedYes

Fingerprint

Sphingomyelin Phosphodiesterase
Pseudomonas Infections
Cystic Fibrosis
Pseudomonas aeruginosa
Acids
Interleukin-8
Ceramides
Pathogens
RNA Interference
Inbred C57BL Mouse
Bacterial Infections
Knockout Mice
Cystic Fibrosis Transmembrane Conductance Regulator
Sphingolipids
Cell death
Metabolism

Keywords

  • Acid sphingomyelinase
  • Ceramide
  • Cystic fibrosis
  • Immune response
  • P. aeruginosa

ASJC Scopus subject areas

  • Cell Biology
  • Pulmonary and Respiratory Medicine
  • Molecular Biology
  • Clinical Biochemistry

Cite this

Defective acid sphingomyelinase pathway with Pseudomonas aeruginosa infection in cystic fibrosis. / Yu, Hong; Zeidan, Youssef; Wu, Bill X.; Jenkins, Russell W.; Flotte, Terence R.; Hannun, Yusuf A.; Virella-Lowell, Isabel.

In: American Journal of Respiratory Cell and Molecular Biology, Vol. 41, No. 3, 01.09.2009, p. 367-375.

Research output: Contribution to journalArticle

Yu, Hong ; Zeidan, Youssef ; Wu, Bill X. ; Jenkins, Russell W. ; Flotte, Terence R. ; Hannun, Yusuf A. ; Virella-Lowell, Isabel. / Defective acid sphingomyelinase pathway with Pseudomonas aeruginosa infection in cystic fibrosis. In: American Journal of Respiratory Cell and Molecular Biology. 2009 ; Vol. 41, No. 3. pp. 367-375.
@article{561cd40a37674639b038758598e57062,
title = "Defective acid sphingomyelinase pathway with Pseudomonas aeruginosa infection in cystic fibrosis",
abstract = "Acid sphingomyelinase (ASMase) is a key enzyme in sphingolipid metabolism, which can be activated by various cellular stress mechanisms including bacterial pathogens. Activation of ASMase generates ceramide, which is important for innateimmuneresponse to eliminate infected pathogens. The current study reveals a defective ASMase pathway after Pseudomonas aeruginosa infection in both a cystic fibrosis (CF) bronchial epithelial cell line (IB3-1 cell) and in the lungs of CF transmembrane conductance regulator (CFTR) knockout (KO) mice as compared with S9 cells and wild-type C57BL/6 mice. ASMase activity and total ceramide levels significantly increased in S9 cells and C57BL/6 mice with P. aeruginosa infection, but not in IB3-1 cells and CFTR KO mice. The silencing of CFTR by CFTR RNAi in S9 cells significantly decreased ASMase activity after bacterial infection as compared with controls. This study also demonstrates that induction of ASMase is responsible for modulating the immune response to bacterial infection. Blocking ASMase activity with specific ASMase RNAi, an ASMase inhibitor, or an ASMase antibody in S9 cells significantly increased IL-8 levels with P. aeruginosa infection compared with controls. Reciprocally, adding exogenous bacterial sphingomyelinase to IB3-1 cells significantly decreased IL-8 levels compared with untreated cells. In addition, silencing of ASMase in S9 cells also significantly decreased bacterial internalization. Adding exogenous bacterial sphingomyelinase to IB3-1 cells reconstituted the cell death response to P. aeruginosa infection. This study demonstrates that the defective ASMase pathway in CF is a key contributor to the unabated IL-8 response with P. aeruginosa infection and to the compromised host response failing to eradicate bacteria.",
keywords = "Acid sphingomyelinase, Ceramide, Cystic fibrosis, Immune response, P. aeruginosa",
author = "Hong Yu and Youssef Zeidan and Wu, {Bill X.} and Jenkins, {Russell W.} and Flotte, {Terence R.} and Hannun, {Yusuf A.} and Isabel Virella-Lowell",
year = "2009",
month = "9",
day = "1",
doi = "10.1165/rcmb.2008-0295OC",
language = "English (US)",
volume = "41",
pages = "367--375",
journal = "American Journal of Respiratory Cell and Molecular Biology",
issn = "1044-1549",
publisher = "American Thoracic Society",
number = "3",

}

TY - JOUR

T1 - Defective acid sphingomyelinase pathway with Pseudomonas aeruginosa infection in cystic fibrosis

AU - Yu, Hong

AU - Zeidan, Youssef

AU - Wu, Bill X.

AU - Jenkins, Russell W.

AU - Flotte, Terence R.

AU - Hannun, Yusuf A.

AU - Virella-Lowell, Isabel

PY - 2009/9/1

Y1 - 2009/9/1

N2 - Acid sphingomyelinase (ASMase) is a key enzyme in sphingolipid metabolism, which can be activated by various cellular stress mechanisms including bacterial pathogens. Activation of ASMase generates ceramide, which is important for innateimmuneresponse to eliminate infected pathogens. The current study reveals a defective ASMase pathway after Pseudomonas aeruginosa infection in both a cystic fibrosis (CF) bronchial epithelial cell line (IB3-1 cell) and in the lungs of CF transmembrane conductance regulator (CFTR) knockout (KO) mice as compared with S9 cells and wild-type C57BL/6 mice. ASMase activity and total ceramide levels significantly increased in S9 cells and C57BL/6 mice with P. aeruginosa infection, but not in IB3-1 cells and CFTR KO mice. The silencing of CFTR by CFTR RNAi in S9 cells significantly decreased ASMase activity after bacterial infection as compared with controls. This study also demonstrates that induction of ASMase is responsible for modulating the immune response to bacterial infection. Blocking ASMase activity with specific ASMase RNAi, an ASMase inhibitor, or an ASMase antibody in S9 cells significantly increased IL-8 levels with P. aeruginosa infection compared with controls. Reciprocally, adding exogenous bacterial sphingomyelinase to IB3-1 cells significantly decreased IL-8 levels compared with untreated cells. In addition, silencing of ASMase in S9 cells also significantly decreased bacterial internalization. Adding exogenous bacterial sphingomyelinase to IB3-1 cells reconstituted the cell death response to P. aeruginosa infection. This study demonstrates that the defective ASMase pathway in CF is a key contributor to the unabated IL-8 response with P. aeruginosa infection and to the compromised host response failing to eradicate bacteria.

AB - Acid sphingomyelinase (ASMase) is a key enzyme in sphingolipid metabolism, which can be activated by various cellular stress mechanisms including bacterial pathogens. Activation of ASMase generates ceramide, which is important for innateimmuneresponse to eliminate infected pathogens. The current study reveals a defective ASMase pathway after Pseudomonas aeruginosa infection in both a cystic fibrosis (CF) bronchial epithelial cell line (IB3-1 cell) and in the lungs of CF transmembrane conductance regulator (CFTR) knockout (KO) mice as compared with S9 cells and wild-type C57BL/6 mice. ASMase activity and total ceramide levels significantly increased in S9 cells and C57BL/6 mice with P. aeruginosa infection, but not in IB3-1 cells and CFTR KO mice. The silencing of CFTR by CFTR RNAi in S9 cells significantly decreased ASMase activity after bacterial infection as compared with controls. This study also demonstrates that induction of ASMase is responsible for modulating the immune response to bacterial infection. Blocking ASMase activity with specific ASMase RNAi, an ASMase inhibitor, or an ASMase antibody in S9 cells significantly increased IL-8 levels with P. aeruginosa infection compared with controls. Reciprocally, adding exogenous bacterial sphingomyelinase to IB3-1 cells significantly decreased IL-8 levels compared with untreated cells. In addition, silencing of ASMase in S9 cells also significantly decreased bacterial internalization. Adding exogenous bacterial sphingomyelinase to IB3-1 cells reconstituted the cell death response to P. aeruginosa infection. This study demonstrates that the defective ASMase pathway in CF is a key contributor to the unabated IL-8 response with P. aeruginosa infection and to the compromised host response failing to eradicate bacteria.

KW - Acid sphingomyelinase

KW - Ceramide

KW - Cystic fibrosis

KW - Immune response

KW - P. aeruginosa

UR - http://www.scopus.com/inward/record.url?scp=67249133362&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67249133362&partnerID=8YFLogxK

U2 - 10.1165/rcmb.2008-0295OC

DO - 10.1165/rcmb.2008-0295OC

M3 - Article

C2 - 19168701

AN - SCOPUS:67249133362

VL - 41

SP - 367

EP - 375

JO - American Journal of Respiratory Cell and Molecular Biology

JF - American Journal of Respiratory Cell and Molecular Biology

SN - 1044-1549

IS - 3

ER -